Do Pot Stocks Belong in Retirement Portfolios?

There are certain situations where an investor may want to add a cannabis company or two to their retirement portfolio, such as a quality long-term company like WeedMD Inc (TSXV:WMD).

| More on:

When crafting a stock portfolio for retirement, there are two major considerations. The first is finding adequate passive income, and the second is finding great long-terms stocks that are stable, have low volatility, and can be relied on long term.

While this sounds exactly opposite of pot stocks, there are a few cannabis companies that could find a place in some investors’ retirement portfolios.

For the past few years, cannabis stocks have been wildly volatile, earning some investors millions, while losing others a considerable amount of money.

Now that the industry has been around for well over a year now, and there isn’t as much buzz around the stocks and therefore less speculation, the volatility has come down considerably.

Just recently, Aphria even opened the possibility for cannabis companies to begin to pay dividends soon, as it grows its free cash flow and no longer needs to invest all its capital in growth.

So, how can pot stocks be right for a retirement portfolio?

Not every investor is going to want to own pot stocks, and those investors who do should keep them as a small portion of your portfolio, but the cannabis industry could represent a great long-term investment from here.

Although you won’t make significant amounts overnight, after the major selloff the industry took last year, these companies are trading at attractive valuations when looking at a long-term investment perspective, so investors who have some room in their portfolios may choose to allocate it to a top long-term cannabis stock.

A company like WeedMD (TSXV:WMD), which has been very cautious with its business plan since day one, is the type of stock you’ll want to be invested in for the long run.

Until now, it’s been a tough balance for cannabis companies and their executives. The best approach, if there were no competitors, would be to take a conservative approach to the market, but since there are a number of competitors, companies have been forced to make high-risk decisions to differentiate themselves.

This has hurt a number of companies that over-leveraged themselves, and it has left some of the companies that remained too conservative lagging behind.

WeedMD has been one of the better-balanced companies, and that’s left it in an optimal position.

At a market cap of just $150 million, the shares are trading at a massive bargain at the moment for a company with the number of opportunities that WeedMD has.

For starters, it’s in a great financial position with a net cash position, giving it major flexibility that a lot of its peers don’t have.

It also has its own in-house extract company, CX industries, which will be a major advantage, as the industry continues to evolve and edibles grow to become a major share of the market.

It has one of the lowest-funded capacity to enterprise value ratios, making it one of the cheapest cannabis stocks in Canada.

Furthermore, it also has its own retail company, Pioneer Cannabis, which will be key to its expansion. Currently, Pioneer operates a store in Burlington, Ontario, and the plan is to open a number of stores in the future, as the regulations in the industry are relaxed.

These major advantages and the position the company has put itself in will almost surely result in long-term success.

If you are looking for a pot stock that could return a lot to you in the short term, WeedMD is probably not your stock.

However, if you are willing to own the company long term and wait for major evolution in the sector, WeedMD could be one of the biggest winners in the industry.

For investors at or in retirement that may want some exposure, there is still a high level of uncertainty in the industry, so even if you do your due diligence and are investing for the long term, it’s still advised to only allocate a very small portion of your portfolio to cannabis stocks.

Fool contributor Daniel Da Costa owns shares of WeedMD Rx Inc.

More on Cannabis Stocks

Farmer smiles near cannabis crop
Cannabis Stocks

TFSA Investors: An Undervalued Cannabis Stock You Can Buy for $500 Right Now

Down almost 70% from all-time highs, Curaleaf is a TSX cannabis stock that trades at an attractive valuation in December…

Read more »

Farmer smiles near cannabis crop
Cannabis Stocks

Can Canopy Growth Stock Finally Recover in 2026, as Donald Trump Might Ease Cannabis Restrictions?

Down over 99% from all-time highs, Canopy Growth stock might recover in 2026 if the Trump administration reclassifies cannabis products.

Read more »

Researcher works in hemp field
Cannabis Stocks

Forget Tilray and Buy This Cannabis Stock if the U.S. Reclassifies Marijuana in 2026

While Tilray stock gained over 40% on Friday, this cannabis company is a better buy if the U.S. reclassifies marijuana…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis Surged 21% on Possible Cannabis Reclassification in the U.S. Is ACB Stock Finally a Good Buy?

Down almost 99% from all-time highs, Aurora Cannabis is a beaten-down marijuana stock that offers upside potential in December 2025.

Read more »

four people hold happy emoji masks
Dividend Stocks

Wary of Mining Companies? A Lower-Risk Way to Get in on the Gold and Silver Surge

Frenco-Nevada (TSX:FNV) stock might be a wiser way to play the run in gold prices this year.

Read more »

Cannabis smoke
Cannabis Stocks

Have Cannabis Stocks Totally Gone Up in Smoke?

Let's dive into whether Canadian cannabis stocks are still investable, and what investors should make of the recent volatility in…

Read more »

Researcher works in hemp field
Cannabis Stocks

1 Undervalued Cannabis Stock to Buy and Hold Over the Next Decade

Green Thumb is a beaten-down cannabis stock that trades at a compelling valuation in September 2025.

Read more »

Researcher works in hemp field
Cannabis Stocks

Pot Stocks Rallied Hard in August: Is There More to Come?

Tilray Brands (TSX:TLRY) and the broad basket of pot stocks could heat up from here.

Read more »